Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCP-TAC vs IR-TAC for Tremors in Liver Transplant Recipients
NCT05089604Phase 4Recruiting
- Sponsor
- University of British Columbia
- Start
- Jan 2023
- Primary completion
- Jan 2026
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in graft rejection, essential tremor (ET), sponsored by University of British Columbia. Started Jan 2023; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
graft rejectionessential tremor (ET)
Beyond the preview
Go deeper on NCT05089604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05089604.